EP2379069
Lyfjagjafaráætlun S1P viðtakablokka
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.12.2009EP published:
4.3.2015EP application number:
09793546.4
EP translation filed:
26.5.2015Grant published:
15.6.2015EPO information:
European Patent Register
Max expiry date:
20.12.2029Expiry date:
20.12.2026Next due date:
31.12.2026
Title:
DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
Timeline
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
LEGANGNEUX, EricAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
139673 PDate:
22.12.2008Country:
US
Number:
09167209Date:
4.8.2009Country:
EP
Supplementary protection
SPC number:
SPC300
Classification
Categories:
A61K 31/192, A61K 31/397, A61K 31/401, A61K 31/445, A61P 37/00, A61P 37/06
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.11.2015
Expires: 20.12.2016
Payer: Árnason Faktor
Number: 8
Paid: 24.11.2016
Expires: 20.12.2017
Payer: Árnason Faktor
Number: 9
Paid: 28.11.2017
Expires: 20.12.2018
Payer: Árnason Faktor
Number: 10
Paid: 26.11.2018
Expires: 20.12.2019
Payer: Árnason Faktor
Number: 11
Paid: 26.11.2019
Expires: 20.12.2020
Payer: Árnason Faktor
Number: 12
Paid: 24.11.2020
Expires: 20.12.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 24.11.2021
Expires: 20.12.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 30.11.2022
Expires: 20.12.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.12.2023
Expires: 20.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 28.11.2024
Expires: 20.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 19.12.2025
Expires: 20.12.2026
Payer: Árnason Faktor ehf.